Results 151 to 160 of about 9,488,957 (383)

Growth Inhibiting Effects of Three Different Plant Extracts on Tribolium castaneum (Herbst) (Tenebrionidae: Coleoptera)

Journal of Bioresource Management, 2015
Petroleum ether, acetone and ethanol extracts of neem, sweet flag, and turmeric were evaluated for their growth inhibiting effects on the Tribolium castaneum at the application rate of 1000, 500, 250 and 125 μg/g food media.
Javed Iqbal, Ghulam Jilani, Muhammad Aslam   +2 more
doaj   +1 more source

The Inhibition of Growth of Bacillus subtilis by Ultra-violet Irradiated Carbohydrates [PDF]

, 1935
Irvin H. Blank, William V. Arnold
openalex   +1 more source

Studies in fundamental chemistry of fuel cell reactions Quarterly report, 1 Apr. - 30 Jun. 1970 [PDF]

Oxygen dissolution reaction, activation energy values, and dendrite growth inhibition in fuel cell ...
Bockris, J. O.
core   +2 more sources

Multidimensional OMICs reveal ARID1A orchestrated control of DNA damage, splicing, and cell cycle in normal‐like and malignant urothelial cells

Molecular Oncology, EarlyView.
Loss of the frequently mutated chromatin remodeler ARID1A, a subunit of the SWI/SNF cBAF complex, results in less open chromatin, alternative splicing, and the failure to stop cells from progressing through the cell cycle after DNA damage in bladder (cancer) cells. Created in BioRender. Epigenetic regulators, such as the SWI/SNF complex, with important
Rebecca M. Schlösser, Florian Krumbach, Eyleen Corrales, Geoffroy Andrieux, Christian Preisinger, Franziska Liss, Alexandra Golzmann, Melanie Boerries, Kerstin Becker, Ruth Knüchel, Stefan Garczyk, Bernhard Lüscher   +11 more
wiley   +1 more source

STUDIES ON THE pH‐RELATIONSHIPS OF ROOT GROWTH AND ITS INHIBITION BY 2:4‐DICHLOROPHENOXYACETIC ACID AND COUMARIN [PDF]

, 1949
L. J. AUDUS
openalex   +1 more source

ShcD adaptor protein drives invasion of triple negative breast cancer cells by aberrant activation of EGFR signaling

Molecular Oncology, EarlyView.
We identified adaptor protein ShcD as upregulated in triple‐negative breast cancer and found its expression to be correlated with reduced patient survival and increased invasion in cell models. Using a proteomic screen, we identified novel ShcD binding partners involved in EGFR signaling pathways.
Hayley R. Lau, Hayley S. Smith, Begüm Alural, Claire E. Martin, Laura A. New, Manali Tilak, Sara L. Banerjee, Hannah N. Robeson, Nicolas Bisson, Anne‐Claude Gingras, Jasmin Lalonde, Nina Jones   +11 more
wiley   +1 more source

STUDIES ON PNEUMOCOCCUS GROWTH INHIBITION [PDF]

, 1926
Shutai T. Woo
openalex   +1 more source

Homochiral growth through enantiomeric cross-inhibition

, 2004
The stability and conservation properties of a recently proposed polymerization model are studied. The achiral (racemic) solution is linearly unstable once the relevant control parameter (here the fidelity of the catalyst) exceeds a critical value.
A. Brandenburg, A. C. Andersen, C. Woese, D. K. Kondepudi, D. K. Kondepudi, D. K. Kondepudi, D. K. Kondepudi, F. Frank, F. H. C. Crick, G. F. Joyce, H. Haken, J. A. D. Wattis, J. A. D. Wattis, J. Bailey, J. L. Bada, J. L. Bada, K. E. Nelson, L. E. Orgel, M. Nilsson, M. Pooga, N. V. Pogodina, P. E. Hare, P. E. Nielsen, P. G. H. Sandars, R. A. Hegstrom, R. Kippenhahn, S. Höfner, S. Rasmussen, T. Tedeschi, V. A. Avetisov, V. I. Goldanskii, W. A. Bonner, Y. Saito   +32 more
core   +4 more sources

Multi‐omic characterization of consensus molecular subtype 1 (CMS1) colorectal cancer with dampened immune response improves precision medicine

Molecular Oncology, EarlyView.
This study highlights the importance of multi‐omic analyses in characterizing colorectal cancers. Indeed, our analysis revealed a rare CMS1 exhibiting dampened immune activation, including reduced PD‐1 expression, moderate CD8+ T‐cell infiltration, and suppressed JAK/STAT pathway.
Livia Concetti, Manuel Scimeca, Julia Bischof, Jonathan Woodsmith, Massimiliano Agostini, Cristina Fiorani, Yufang Shi, Eleonora Candi, Gerry Melino, Alessandro Mauriello, Giuseppe S. Sica   +10 more
wiley   +1 more source

Targeting the AKT/mTOR pathway attenuates the metastatic potential of colorectal carcinoma circulating tumor cells in a murine xenotransplantation model

Molecular Oncology, EarlyView.
Dual targeting of AKT and mTOR using MK2206 and RAD001 reduces tumor burden in an intracardiac colon cancer circulating tumor cell xenotransplantation model. Analysis of AKT isoform‐specific knockdowns in CTC‐MCC‐41 reveals differentially regulated proteins and phospho‐proteins by liquid chromatography coupled mass spectrometry. Circulating tumor cells
Daniel J. Smit, Thais Pereira‐Veiga, Helena Brauer, Michael Horn, Paula Nissen, Thomas Mair, Bente Siebels, Hannah Voß, Ruimeng Zhuang, Marie‐Therese Haider, Desiree Loreth, Margarita Iskhakova, Bele Lindemann, Julian Kött, Laure Cayrefourcq, Jasmin Wellbrock, Hartmut Schlüter, Klaus Pantel, Catherine Alix‐Panabières, Manfred Jücker   +19 more
wiley   +1 more source